Drug Trial Radar · NCT03573323
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Last checked: Nov 20, 2026Latest source record: Jul 28, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,027
Actual
Start
Nov 9, 2018
Primary completion
Jul 15, 2019
Study completion Jan 8, 2020
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Jun 29, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy and safety of ixekizumab to guselkumab in participants with moderate-to-severe plaque psoriasis.
Conditions
- Plaque Psoriasis
Interventions
IxekizumabDrug
Administered SC
GuselkumabDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving 100% Improvement From Baseline in Psoriasis Area and Severity Index (PASI 100)Time frame: Week 12
Locations
124 sites in 3 countries. Site status is shown where the registry gives one.
Total Skin and Beauty Dermatology Center PC
Birmingham, Alabama
University of Alabama at Birmingham
Birmingham, Alabama
Alliance Dermatology and Mohs Center
Phoenix, Arizona
Perseverance Research Center
Scottsdale, Arizona
Johnson Dermatology
Fort Smith, Arkansas
Bakersfield Dermatology and Skin Cancer Medical Group
Bakersfield, California
Wallace Medical Group, Inc.
Beverly Hills, California
California Dermatology and Clinical Research Institute
Encinitas, California
Tien Q. Nguyen, MD inc. DBA First OC Dermatology
Fountain Valley, California
Center for Dermatology Clinical Research, Inc.
Fremont, California
Advanced Research Center
Los Alamitos, California
Axis Clinical Trials
Los Angeles, California
Dermatology Clinical Trials
Newport Beach, California
Quest Dermatology Research
Northridge, California
Northern California Research Corporation
Sacramento, California
Advanced Research Center
San Diego, California
Medical Center for Clinical Research
San Diego, California
University Clinical Trials, Inc.
San Diego, California
Synergy Dermatology
San Francisco, California
Southern California Dermatology
Santa Ana, California
Mosaic Dermatology
Santa Monica, California
Clinical Science Institute
Santa Monica, California
Unison Clinical Trials
Sherman Oaks, California
Care Access Research-Walnut Creek
Walnut Creek, California
Dermatology Physicians of Connecticut
Shelton, Connecticut
Florida Academic Dermatology Centers
Coral Gables, Florida
Olympian Clinical Research
Largo, Florida
Suncoast Research Group, LLC
Miami, Florida
Miami Dermatology & Laser Research
Miami, Florida
Suncoast Clinical Research
New Port Richey, Florida
Renstar Medical Research
Ocala, Florida
Sensible Healthcare
Ocoee, Florida
Park Avenue Dermatology
Orange Park, Florida
International Clinical Research
Sanford, Florida
MOORE Clinical Research
Tampa, Florida
ForCare Clinical Research
Tampa, Florida
Olympian Clinical Research
Tampa, Florida
Atlanta Dermatology, Vein Research Center, PC
Alpharetta, Georgia
Skin Care Physicians of Georgia
Macon, Georgia
Arlington Dermatology
Rolling Meadows, Illinois
Showing 40 of 124 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.